{
    "Trade/Device Name(s)": [
        "Wieslab\u2122 Cap PR-3 ANCA",
        "Capture-PR3-ANCA test kit"
    ],
    "Submitter Information": "Euro-Diagnostica AB",
    "510(k) Number": "K051458",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MOB"
    ],
    "Summary Letter Date": "June 1, 2005",
    "Summary Letter Received Date": "June 2, 2005",
    "Submission Date": "May 4, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to proteinase 3 (PR3)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Wieslab\u2122 Cap PR-3 ANCA ELISA kit for detection and semi-quantitation of IgG antibodies to proteinase 3 in human serum.",
    "Indications for Use Summary": "For detection and semi-quantitation of IgG antibodies to PR3 in human serum as an aid to diagnosis of Wegener's granulomatosis in symptomatic patients; not for screening healthy populations.",
    "fda_folder": "Immunology"
}